Red Cedar Capital’s Thermo Fisher Scientific TMO Stock Holding History

Red Cedar Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$156K	Buy	284 +32	+13%	+$17K	0.1%	65
2022 Q3	$128K	Hold	252	–	–	0.09%	70
2022 Q2	$137K	Buy	252 +36	+17%	+$19.8K	0.09%	69
2022 Q1	$128K	Buy	216 +30	+16%	+$17.2K	0.08%	71
2021 Q4	$124K	Hold	186	–	–	0.07%	72
2021 Q3	$106K	Hold	186	–	–	0.07%	71
2021 Q2	$94K	Buy	186 +182	+4,550%	+$85.9K	0.06%	74
2021 Q1	$2K	Buy	+4	New	+$1.91K	﹤0.01%	142

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Red Cedar Capital's TMO Position: Q4 2022 in Review

Red Cedar Capital increased its Thermo Fisher Scientific (TMO) stake by 13% in Q4 2022, buying an estimated $17K and bringing the position to 284 shares worth $156K. The position accounts for 0.1% of the portfolio, ranked #65.

Red Cedar Capital first reported a position in TMO in Q1 2021 and has held it in 8 quarters since. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Red Cedar Capital held 284 shares of Thermo Fisher Scientific worth $156K as of Q4 2022.
Red Cedar Capital bought 32 Thermo Fisher Scientific shares in Q4 2022, an estimated $17K.
Thermo Fisher Scientific made up 0.1% of Red Cedar Capital's portfolio in Q4 2022, its #65 holding.
Red Cedar Capital first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 8 quarters since.
2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Red Cedar Capital's 13F filing for Q4 2022, filed 6 Feb 2023.